Dr. Sayed S. Khatami, M.D.
Gastroenterology (Gastroenterology Physician)
8877 Mentor Ave Ste 105
Mentor, OH 44060
Who else practices at this address →
Lake County includes primary care (8% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 419
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
OH license 35082799 · PA license MD486496
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Summa Health System Akron, OH
- Lake Health Concord, OH
- Meadville Medical Center Meadville, PA
Medical groups
- Summa Physicians LLC (671 clinicians)
- Meadville Medical Center (143 clinicians)
- Dayton Gastroenterology, LLC (74 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 419
- Services billed
- 795
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 173 | 129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | 96 |
| New patient office or other outpatient visit, 30-44 minutes | 91 | 91 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 91 | 62 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 54 | 53 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | 54 |
| Biopsy of large bowel using a flexible endoscope | 36 | 36 |
| Removal of external hemorrhoids by rubber banding | 32 | 15 |
| Dilation of esophagus | 23 | 23 |
| New patient office or other outpatient visit, 45-59 minutes | 23 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Mentor, OH | 448 |
| Pantoprazole Sodium Other prescribers in Mentor, OH | 222 |
| Famotidine Other prescribers in Mentor, OH | 116 |
| Creon (lipase/protease/amylase) Other prescribers in Mentor, OH | 50 |
| Ondansetron Hcl Other prescribers in Mentor, OH | 41 |
| Linzess (linaclotide) Other prescribers in Mentor, OH | 39 |
| Spironolactone Other prescribers in Mentor, OH | 32 |
| Sucralfate Other prescribers in Mentor, OH | 31 |
| Dicyclomine Hcl Other prescribers in Mentor, OH | 30 |
| Furosemide Other prescribers in Mentor, OH | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 99 payments worth $1,679 in total to this clinician.
| AbbVie Inc. | $206 |
|---|---|
| Pfizer Inc. | $175 |
| Aimmune Therapeutics, Inc. | $173 |
| Madrigal Pharmaceuticals | $168 |
| Janssen Biotech, Inc. | $153 |
| Qol Medical, LLC | $124 |
| Lilly USA, LLC | $93.93 |
| Gilead Sciences, Inc. | $81.43 |
| Food and Beverage | $1,669 |
|---|---|
| Education | $10.48 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc Apr 10, 2025 | Education in-kind | $10.48 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,554 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Bausch Health US, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.